Abstract book will be available in May
Every toxicologist, regardless of whether they are active in academia, industry, or the regulatory field, has had to deal with research results not being applicable to everyone. This can be due to a specific study design or exclusion of certain individuals from participating in research. Even in present day drug development, we see examples of widespread adverse effects after compounds have entered the market, because large groups of the population are being left out in (clinical) studies. Standard research, one size, does not fit all. But what should we do? How can we address this? And what can we do to be more inclusive?
This annual NVT meeting will highlight the progress made and challenges ahead spanning different fields of toxicology. We will focus on selecting the right study design and discuss how toxicology can be more inclusive. We will cover all sizes: from nanoparticles to biomaterials and from personalized medicine to population risk assessment.
All participants are encouraged to submit an abstract to present their research via a pitch or poster (instructions will follow). We are happy to invite you to the meeting at Congresscentrum de Reehorst, Ede. The date for the ‘young scientists’ day is June 7th. The ‘NVT-member’ day, including the annual NVT business meeting, is scheduled for June 8th.
|President NVT||Paul Jennings|
|Organizing committee||Nathalie Dierichs, Irene Gosselink, Joyce van der Heijden, Viënna van de Laarschot, Julia Meerman, Kiri Romano Olmedo, Hans Bouwmeester, Laura Hondebrink, Juliette Legler, Yvonne Staal, Peter Theunissen.|